Page last updated: 2024-10-26

3,4-dihydroxybenzohydroxamic acid and Fibroma, Shope

3,4-dihydroxybenzohydroxamic acid has been researched along with Fibroma, Shope in 2 studies

Research Excerpts

ExcerptRelevanceReference
" However, appeal for the long-term use of HU in HIV-1 infection may be limited by its propensity to induce hematopoietic toxicity."1.31Suppression of retrovirus-induced immunodeficiency disease (murine AIDS) by trimidox and didox: novel ribonucleotide reductase inhibitors with less bone marrow toxicity than hydroxyurea. ( Ahmed, MM; Chendil, D; Elford, HL; Gallicchio, VS; Greenberg, RN; Mampuru, LJ; Mayhew, CN; Phillips, JD, 2002)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mayhew, CN2
Mampuru, LJ1
Chendil, D1
Ahmed, MM1
Phillips, JD2
Greenberg, RN1
Elford, HL2
Gallicchio, VS2
Sumpter, R1
Inayat, M1
Cibull, M1

Other Studies

2 other studies available for 3,4-dihydroxybenzohydroxamic acid and Fibroma, Shope

ArticleYear
Suppression of retrovirus-induced immunodeficiency disease (murine AIDS) by trimidox and didox: novel ribonucleotide reductase inhibitors with less bone marrow toxicity than hydroxyurea.
    Antiviral research, 2002, Volume: 56, Issue:2

    Topics: Animals; Benzamidines; Bone Marrow Cells; DNA, Viral; Female; Femur; Free Radical Scavengers; Hemato

2002
Combination of inhibitors of lymphocyte activation (hydroxyurea, trimidox, and didox) and reverse transcriptase (didanosine) suppresses development of murine retrovirus-induced lymphoproliferative disease.
    Antiviral research, 2005, Volume: 65, Issue:1

    Topics: Animals; Antiviral Agents; B-Lymphocytes; Benzamidines; Didanosine; Drug Therapy, Combination; Enzym

2005